Abstract
We have studied the effect of chlorpromazine and PGF<inf>2α</inf>, on the blood and amniotic fluid levels of prolactin over a 1- hour period of time in women who were in the 14th— 20th week of gestation. Following intramuscular injection of chlorpromazine, maternal plasma prolactin rose 1.0- to 2.5-fold. No significant change was noted in maternal plasma after PGF<inf>2α</inf>, administration. Amniotic fluid prolactin declined by 6 to 56%. These changes may be dilutional.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 282-286 |
| Number of pages | 5 |
| Journal | Obstetrics and Gynecology |
| Volume | 47 |
| Issue number | 3 |
| State | Published - 1976 |
Fingerprint
ASJC Scopus subject areas
- Obstetrics and Gynecology
Cite this
Studies of maternal plasma prolactin and amniotic fluid prolactin : Effects of chlorpromazine and prostaglandin f2α. / Freeman, Ruth; Lev-Gur, Michael; Boyar, Robert M.; Schulman, Harold.
In: Obstetrics and Gynecology, Vol. 47, No. 3, 1976, p. 282-286.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Studies of maternal plasma prolactin and amniotic fluid prolactin
T2 - Effects of chlorpromazine and prostaglandin f2α
AU - Freeman, Ruth
AU - Lev-Gur, Michael
AU - Boyar, Robert M.
AU - Schulman, Harold
PY - 1976
Y1 - 1976
N2 - We have studied the effect of chlorpromazine and PGF2α, on the blood and amniotic fluid levels of prolactin over a 1- hour period of time in women who were in the 14th— 20th week of gestation. Following intramuscular injection of chlorpromazine, maternal plasma prolactin rose 1.0- to 2.5-fold. No significant change was noted in maternal plasma after PGF2α, administration. Amniotic fluid prolactin declined by 6 to 56%. These changes may be dilutional.
AB - We have studied the effect of chlorpromazine and PGF2α, on the blood and amniotic fluid levels of prolactin over a 1- hour period of time in women who were in the 14th— 20th week of gestation. Following intramuscular injection of chlorpromazine, maternal plasma prolactin rose 1.0- to 2.5-fold. No significant change was noted in maternal plasma after PGF2α, administration. Amniotic fluid prolactin declined by 6 to 56%. These changes may be dilutional.
UR - http://www.scopus.com/inward/record.url?scp=0017229289&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0017229289&partnerID=8YFLogxK
M3 - Article
C2 - 2892
AN - SCOPUS:0017229289
VL - 47
SP - 282
EP - 286
JO - Obstetrics and Gynecology
JF - Obstetrics and Gynecology
SN - 0029-7844
IS - 3
ER -